Ask AI
ProCE Banner Activity

Risk Stratification in Polycythemia Vera and Essential Thrombocythemia: Applying Prognostic Scoring Systems in Practice

Slideset

Downloadable slideset on risk stratification models that incorporate clinical, hematologic, and molecular factors currently used to guide treatment decisions and personalize the management of essential thrombocythemia and polycythemia vera.

Released: February 03, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme LLC

Target Audience

This activity is intended for hematologists and other healthcare professionals caring for patients with essential thrombocythemia and polycythemia vera. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Utilize prognostic scoring systems and immune biomarker data (eg, Triple A model, MIPSS-ET, MIPSS-PV) to assess thrombotic risk and guide personalized treatment planning